New York, NY, December 1, 2021 – Albaron Partners, LP (“Albaron”), a U.S. private equity firm focused on acquiring majority stakes of companies in the specialty healthcare services sector, today announced that Lincoln Richards has joined the investment team as a Vice President.

Richards will be responsible for evaluating potential acquisition targets, conducting due diligence, and overseeing portfolio company operations. He joins Albaron from private equity firm TZP Group, where he was an Associate. Prior to TZP Group, he spent two years on the Sellside M&A team at McColl Partners (acquired by Deloitte). Richards earned his BS degree from Duke University.

“We are thrilled to welcome Lincoln to the firm,” said Damian Dalla-Longa, Partner at Albaron.
“As a recognized emerging private equity leader, he knows the industry and understands why Albaron is a special place to work. We believe that the firm’s continued success is a direct result of our exceptional talent and distinctive culture and are excited to see what we will accomplish together with Lincoln as part of our team.”


Albaron is a U.S. private equity firm that invests in and helps accelerate the growth of physician practice groups and microcap healthcare companies. The firm’s goal is to build best-in-class healthcare services platforms that maximize outcomes for all constituents – patients, providers, payors and investors. Albaron’s team is comprised of a seasoned cohort of operating experts and investment professionals who are uniquely qualified to realize significant value through strategic insights, operating support and accretive acquisitions. The team works collaboratively with partnering management teams and leverages its network of industry experts to augment its capabilities. For more information, visit:


This communication expressly or implicitly contains certain forward-looking statements that involve risks and uncertainties, including statements regarding expectations for Albaron following its appointment of Lincoln Richards as Vice President. If any of these risks or uncertainties materialize, or if any of Albaron’s assumptions prove incorrect, Albaron’s results could differ materially from the results expressed or implied by these forward-looking statements. All forward-looking statements in this communication are based on information available to Albaron as of the date of this communication, and Albaron does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.